$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
克唑替尼靶向ALK治疗小儿间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤
2025-10-19 11:44:20
Check Details
吉非替尼治疗肺癌的临床试验
2025-10-19 11:44:20
Check Details
克唑替尼治疗KLC1-ALK融合MET基因扩增阳性肺癌患者脑转移
2025-10-19 11:44:20
Check Details
厄洛替尼提高非小细胞肺癌患者生存期
2025-10-19 11:44:20
Check Details
艾乐替尼在克唑替尼难治性肺癌患者中实现长期生存
2025-10-19 11:44:20
Check Details
克唑替尼和化疗在EGFR突变和ALK基因重排肺腺癌患者中的反应
2025-10-19 11:44:20
Check Details
克唑替尼治疗非小细胞肺癌患者
2025-10-19 11:44:20
Check Details
克唑替尼诱导食管溃疡的病例报告
2025-10-19 11:44:20
Check Details
奥希替尼治疗EGFR突变的晚期NSCLC患者的有效性
2025-10-19 11:44:20
Check Details
阿法替尼延长肺癌患者的中位总生存期
2025-10-19 11:44:20
Check Details
色瑞替尼对肺癌脑转移的治疗效果
2025-10-19 11:44:20
Check Details
艾乐替尼治疗肺癌降低患者的死亡风险
2025-10-19 11:44:20
Check Details
1
2
...
9081
9082
9083
9084
9085
9086
9087
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
2
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
3
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
4
Complete Guide to Dosage and Dose Adjustment of Entrectinib
5
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
6
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
7
Sopyrronium Bromide (Sofdra) for Hyperhidrosis: Uses, Mechanism and Facial Application Risks
8
Optimal Dosing Time and Medication Principles of Vigabatrin (Sabril)
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
12
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC